These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity. Xu Y; Tao YX Neuroreport; 2004 Feb; 15(2):263-6. PubMed ID: 15076749 [TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor antagonists protect amyloid-beta damaged neurons from microglia-mediated death. Bate C; Kempster S; Williams A Neuropharmacology; 2006 Aug; 51(2):173-81. PubMed ID: 16678220 [TBL] [Abstract][Full Text] [Related]
6. Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival. Zhu P; DeCoster MA; Bazan NG J Neurosci Res; 2004 Aug; 77(4):525-31. PubMed ID: 15264222 [TBL] [Abstract][Full Text] [Related]
7. Modulation of signal transduction in rat synaptoneurosomes by platelet activating factor. Domańska-Janik K; Zabłocka B Mol Chem Neuropathol; 1995 May; 25(1):51-67. PubMed ID: 7546018 [TBL] [Abstract][Full Text] [Related]
9. Neuronal damage by secretory phospholipase A2: modulation by cytosolic phospholipase A2, platelet-activating factor, and cyclooxygenase-2 in neuronal cells in culture. Kolko M; Rodriguez de Turco EB; Diemer NH; Bazan NG Neurosci Lett; 2003 Feb; 338(2):164-8. PubMed ID: 12566178 [TBL] [Abstract][Full Text] [Related]
10. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation. Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882 [TBL] [Abstract][Full Text] [Related]
11. In vitro hypoxia of cortical and hippocampal CA1 neurons: glutamate, nitric oxide, and platelet activating factor participate in the mechanism of selective neural death in CA1 neurons. Ohmori T; Hirashima Y; Kurimoto M; Endo S; Takaku A Brain Res; 1996 Dec; 743(1-2):109-15. PubMed ID: 9017237 [TBL] [Abstract][Full Text] [Related]
12. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study). Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758 [TBL] [Abstract][Full Text] [Related]
13. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock. De Kimpe SJ; Thiemermann C; Vane JR Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795 [TBL] [Abstract][Full Text] [Related]
17. Effect of platelet activating factor antagonists on cultured rat mesangial cells. Neuwirth R; Singhal P; Satriano JA; Braquet P; Schlondorff D J Pharmacol Exp Ther; 1987 Nov; 243(2):409-14. PubMed ID: 3119816 [TBL] [Abstract][Full Text] [Related]
18. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885 [TBL] [Abstract][Full Text] [Related]
19. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat. Zhou WG; Chao W; Levine BA; Olson MS Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964 [TBL] [Abstract][Full Text] [Related]
20. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei. Grassi S; Francescangeli E; Goracci G; Pettorossi VE J Neurophysiol; 1998 Jun; 79(6):3266-71. PubMed ID: 9636125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]